#Prostatecancer #Deciphergenomictest #genomicscore #patientempowerment #prostatecancertreatment #prostatehealth
In this episode Dr. Geo talks with Dr. Elai Davicioni, a prominent scientist and Medical Director of the prostate section at Veracyte, who joins us all the way from Italy (pardon the internet connection and enjoy the knowledge!). They discuss the Decipher genomic test, its development, and its significance in providing personalized diagnosis and treatment plans for prostate cancer. Dr. Davicioni delves into the genomic score, machine learning, and the future of genomics in medicine. Patients and practitioners alike will gain valuable insights into the importance of patient empowerment and how the Decipher test can guide treatment decisions, helping manage prostate cancer more effectively.
Key Topics Discussed:
- The development and significance of the Decipher genomic test
- Personalized diagnosis and treatment plans for prostate cancer
- The role of genomic score and machine learning in modern medicine
- The future of genomics in patient care
- Empowering patients to make informed treatment decisions
📚 Chapters
00:00 Genomic Revolution in Prostate Cancer with Dr. Elai Davicioni
00:46 Understanding Genomics and the Decipher Test
04:27 The Journey of Developing the Decipher Test
08:41 The Importance of Collaboration in Medical Research
13:12 Decipher Test: Genes and Metastatic Potential
26:13 Empowering Patients: Shared Decision Making and Personalized Treatment
28:32 Motivating Patients: Navigating Cancer Treatment
30:22 The Role of Hormone Therapy in Prostate Cancer Treatment
31:53 Challenges in Cancer Treatment and Precision Medicine
34:35 Understanding the Genomic Score of the Decipher Test
📌Thank You To Our Sponsors
We thank our July Sponsors:
The Decipher Test: The Decipher Prostate Test by Veracyte analyzes specific genes in a prostate tumor to assess cancer aggressiveness, aiding in personalized treatment decisions and improving patient outcomes. Learn more about the Decipher Prostate Test here [[ Ссылка ]].
ExoDx: The ExoDx Prostate Score is a non-invasive urine test for assessing the risk of aggressive prostate cancer, using cancer-specific genomic biomarkers. Scores below 15.6 indicate low risk, while scores above 15.6 indicate higher risk. Decisions on further actions, such as biopsies, should involve shared decision-making between the doctor and patient. Learn more about ExoDx here [[ Ссылка ]].
XY Wellness: XY Wellness provides a high-value roadmap to health and wellness for men with prostate cancer. Co-founded by our Chief Medical Officer, they aim to help men thrive post-diagnosis. [Learn more about XY Wellness here [[ Ссылка ]].
📕 Get Dr. Geo’s FreeEbook- A Guide to Improve Prostate Problems Naturally [ Ссылка ]
📌 Dr. Geo’s Social Media and Websites
Instagram: [ Ссылка ]
Facebook: [ Ссылка ]
LinkedIn: [ Ссылка ]
Website: [ Ссылка ]
XY Wellness- Prostate Health Supplements - [ Ссылка ]
Mr. Happy- Supplements for Men- [ Ссылка ]
#ProstateCancer #DrGeoPodcast #DecipherTest #GenomicMedicine #PersonalizedTreatment #PatientEmpowerment #CancerResearch #ProstateHealth #MedicalInnovation #Genomics #PrecisionMedicine #HormoneTherapy #CancerTreatment #HealthPodcast #PatientCare #ProstateCancerAwareness #MedicalScience #HealthInnovation #ElaiDavicioni #veracyte #decipher
______________________________________________________________________
DISCLAIMER: This audio is educational and does not constitute medical advice. This audio's content is my opinion, not that of my employer(s) or any affiliated company.
Use of this information is at your own risk. Geovanni Espinosa, N.D., will not assume any liability for any direct or indirect losses or damages resulting from using the information in this video, including but not limited to economic loss, injury, illness, or death.
